Prestige Consumer Healthcare (PBH) Interest Coverage Ratio Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) Interest Coverage Ratio Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | -28.01% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 41.72% |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | 157.37 Mn | -10.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.31% |
| Sep 30, 2025 | -19.64% |
| Jun 30, 2025 | -16.64% |
| Mar 31, 2025 | -3.69% |
| Dec 31, 2024 | 17.66% |
| Sep 30, 2024 | 12.09% |
| Jun 30, 2024 | -1.78% |
| Mar 31, 2024 | -42.24% |
| Dec 31, 2023 | 7.86% |
| Sep 30, 2023 | 6.50% |
| Jun 30, 2023 | 9.64% |
| Mar 31, 2023 | 108.59% |
| Dec 31, 2022 | 97.03% |
| Sep 30, 2022 | 21.96% |
| Jun 30, 2022 | 102.06% |
| Mar 31, 2022 | -44.21% |
| Dec 31, 2021 | 7.14% |
| Sep 30, 2021 | 13.39% |
| Jun 30, 2021 | 24.34% |
| Mar 31, 2021 | 68.90% |